Silver Book Fact

A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.

PhRMA Japan. Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer; 10-Sep-2000

Reference

Title
Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer
Publication Date
10-Sep-2000
Authors
PhRMA Japan

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Studies have shown that active medical management of Alzheimer’s disease can significantly improve quality-of-life for the individual through all stages of the disease.  
  • Impact of a 5-Year Delay in Onset by Stage of Disease, Americans Age 65 and Older with Alzheimer’s Disease, 2050  
  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2020 total cost of care (for all payers) for all people…